References
- Inaba T. Cocaine: pharmacokinetics and biotransformation in man. Can J Physiol Pharmacol 1989; 67: 1154–1157
- Stewart D. J., Inaba T., Tang B. K., Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci 1977; 20: 1557–1563
- Stewart D. J., Inaba T., Lucassen M., Kalow W. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Titer 1979; 25: 464–468
- Hoffman R. S., Henry G. C., Howland M. A., Weisman R. S., Weil L., Goldfrank L. R. Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 1992; 21: 247–253
- Om A., Ellahham S., Ornato J. P., et al. Medical complications of cocaine: possible relationship to low plasma cholinesterase enzyme. Am Heart J 1993; 125: 1114–1117
- Devenyi P. Cocaine complications and pseudocho-linesterase. Ann Intern Med 1989; 110: 167–168
- Kalow W., Genest K. A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. Can J Biochem Physiol 1957; 35: 339–346
- Harris H., Whittaker M. Differential inhibition of human serum cholinesterase with fluoride: Recognition of two new phenotypes. Nature 1961; 191: 496–498
- La Du B. N., Bartels C. F., Nogueira C. P., et al. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants. Clin Biochem 1990; 23: 423–431
- Dietz A. A., Rubinstein H. M., Lubrano T. Colorimetric determination of serum cholinesterase and its genetic variants by the propionylthiocholine-dithiobis (nitro-benzoic acid) procedure. Clin Chem 1973; 19: 1309–1313
- Kambam J. R., Naukam R., Berman M. L. Inhibition of pseudocholinesterase activity protects from cocaine-induced cardiorespiratory toxicity in rats. /. Lab Clin Med 1992; 119: 553–556
- Kambam J., Mets B., Hickman R., Janicki P., James M. F., Kirsch R. The effects of inhibition of plasma cholinesterase activity on systemic toxicity and blood catecholamine levels from cocaine infusion in pigs. J Lab Clin Med 1993; 122: 188–196
- Hoffman R. S., Henry G. C., Wax P. M., Weisman R. S., Howland M. A., Goldfrank L. R. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J Pharmacol Exp Titer 1992; 263: 698–702
- Hoffman R. S., Morasco R., Goldfrank L. R. Human plasma cholinesterase protects against cocaine toxicity in mice. Vet Hum Toxicol 1993; 35: 349a
- Johns M. E., Henderson R. L. Cocaine use by the otolaryngologist: a survey. Trans Am Acad Ophthalmol Otolaryngol 1977; 84: 969–973
- Feehan H. F., Mancusi-Ungaro A. The use of cocaine as a topical anesthetic in nasal surgery. A survey report. Plast Reconstr Surg 1976; 57: 62–65